Impacts of the Covid-19 pandemic on enrollment in medications for opioid use disorder (Moud) in Vancouver, Canada
An interrupted time series analysis
Bibliographic Data
| ID | 14909342 |
|---|---|
| Authors | M Eugenia Socias (0000-0003-2556-7049, University of British Columbia, corresponding author), Jin Cheol Choi (British Columbia Centre on Substance Use), Nadia Fairbairn (0000-0002-4195-3284, University of British Columbia), Cheyenne Johnson, C Erwin Johnson (0000-0003-2462-0813, University of British Columbia), Dean Wilson (British Columbia Centre on Substance Use), Kora Debeck (0000-0003-2045-1653, Simon Fraser University), Rupinder Brar (0000-0002-5248-4639, Vancouver Coastal Health), K Hayashi (0000-0003-3843-2928, Simon Fraser University) |
| Year | 2023 |
| Volume | 118 |
| Pages | 104075 |
| Publication date | 2023-08-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2023.104075 |
| PMID | 37271070 |
| OpenAlex | W4377289862 |
| Language | EN |
| Citations received | 3 |
| References cited | 20 |
Despite immediate improvements in MOUD enrollment in the post-COVID-19 period, this beneficial trend reversed over time. RMG opioids appeared to have provided additional benefits to sustain retention in OUD care
Buprenorphine · Coronavirus disease 2019 (COVID-19 · Methadone · Opiate Substitution Treatment · Opioid · Opioid use disorder · Pandemic · Psychiatry · Sociology · Demography · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Prenatal Substance Exposure Effects · Internal Medicine
Mortality risk during and after opioid substitution treatment
Modelling the combined impact of interventions in averting deaths during a synthetic‐opioid overdose epidemic
Interrupted time series regression for the evaluation of public health interventions
Segmented regression analysis of interrupted time series studies in medication use research
Opioid agonist treatment and patient outcomes during the Covid ‐19 pandemic in south east Sydney, Australia
Living Under Coronavirus and Injecting Drugs in Bristol (Lucid-B)
Impact of the Covid-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada
Pathways between Covid-19 public health responses and increasing overdose risks
You'll come in and dose even in a global pandemic”
| Unique citing works | 3 |
|---|---|
| Citations per year | 1,5 |
| Citation span | 2024 - 2026 (3) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 3 |